A glance around the walls of Barry J. Byrnes office reveals a lot about the pediatric cardiologist who runs thePowell Gene Therapy Center at University of Florida (UF).
In one corner is an unusual painting by 9-year-old Will Barkowsky of Jacksonville, Fla. Will, the first boy with Duchenne muscular dystrophy to takeSarepta Therapeutics exon-skipping medication Exondys 51 (eteplirsen), put together his oil-on-canvas masterpiece using the tire tracks of his wheelchair, making sure the colors didnt mix.
Nearby is a movie poster for The Ataxian an award-winning 2015 documentary by Kevin Schlanser and Zack Bennett about 17-year-old Kyle Bryant, who despite having Friedreichs ataxia embarks on a cross-country bicycle trip with three buddies.
Another movie poster advertises Extraordinary Measures, the 2010 tearjerker starring Brendan Fraser as John Crowley the father of two kids with Pompe disease and later, the founder of Amicus Therapeutics and Harrison Ford as fictional researcher Robert Stonehill, who discovers a treatment for the genetic disorder that eventually saves the lives of Crowleys children.
Theres also a model of a Blalock-Taussig shunt frequently used in congenital heart surgery, as well as one of an adeno-associated virus (AAV) vector, along with a prominent photo of Byrne with Ron Bartek, co-founder and director of the Friedreichs Ataxia Research Alliance (FARA).
Friedreichs ataxia is where were putting most of our efforts now, said Byrne, who spoke to BioNews Services publisher of this website at length during a recent visit to his lab in Gainesville, Fla.
Byrne, along with Jerry Mendell, MD, a neurologist with Nationwide Childrens Hospital in Columbus, Ohio, hosted a Nov. 20 webinar on gene therapy organized by the National Organization for Rare Disorders (NORD) and the American Society for Gene & Cell Therapy.
The two experts were introduced by Katie Kowalski, senior program manager for NORDs Educational Initiatives. The webinar, Understanding the Gene Therapy Process and Aftercare, was the fourth in a five-part series underwritten by Amicus and Sarepta, as well as two other companies, Avrobio and Bluebird Bio.
The final webinar in the series, Life After Gene Therapy, is scheduled for Dec. 18.
Mendell, who heads Nationwides Center for Gene Therapy, specializes in gene therapy research for Duchenne as well as limb-girdle muscular dystrophy, spinal muscular atrophy (SMA) and X-linked myotubular myopathy. He was a principal investigator for the Novartis therapy Zolgensma, which uses an AAV vector to carry a working version of SMN1, the mutated gene in people with SMA.
Zolgensma won approval from the U.S. Food and Drug Administration (FDA) in May 2019 as the first gene therapy to treat SMA in infants up to 2 years of age.
At $2.125 million per patient, the hour-long Zolgensma infusion is the most expensive medicine in history. The cost easily eclipses that of the only other FDA-approved treatment for SMA, BiogensSpinraza(nusinersen), which retails for $750,000 the first year and $375,000 every year after.
Many of my colleagues have been trying to make inroads for years, Mendell said. When we first got into the gene therapy domain, we were limited by technology. We could not make enough virus for the kind of impact were having now. But technology has improved, and we can now deliver genes through circulation to reach all muscles.
Regardless of the disease, he said, its extremely important to confirm the patients specific mutation before anything else.
This is critical, because you dont want to deliver the wrong kind of gene in a disease like Friedreichs ataxia. That goes for all gene therapy trials, he said. Next, we want to check for pre-existing antibodies, whether theyre acquired from the environment or from close contact. They bind to the AAV and block entry to the target organ.
Checking for those antibodies requires a blood test. It generally takes 4-7 days to return lab results a nailbiting time for patients and families, Mendell said, because theyre waiting to be approved for enrollment in the trial.
Byrne estimated that 50-60% of all individuals may have been exposed to AAV.
Prior exposure at any level to any AAV infection is an exclusion in most studies, he said, noting that people who travel frequently or who have respiratory or gastrointestinal conditions are particularly susceptible. We are learning a lot about what thresholds are effective. Its about 10% of newborns and about 50% of those of school age and adulthood.
Patients must also be in general good health except, of course, for the genetic disease being treated. MRI and blood tests are done to rule out diabetes or any evidence of heart, liver, or kidney problems.
We put the patient to sleep so theres really no pain involved, Mendell said. We also use local numbing medicine, even though the patient is asleep, so theres no pain or discomfort.
The Powell Gene Therapy Center was established in 1996 the year before Byrne joined UF by Nicholas Muzyczka, PhD, who performed groundbreaking work on AAVs in the 1980s. The center has a dozen individual labs working in neuroscience and molecular genetics.
Byrne said that because gene therapy fundamentally changes many of the bodys cells, screening is crucial.
This is often a one-way street, in that since the effects are long-lasting, other experimental studies may not accept patients who have received gene therapy of any kind in the past, Byrne said. One must have the clinical features required of the study and meet certain functional and age criteria.
To prepare for screening, patients or their parents must read the informed consent and understand what the risks and benefits are. Genetic counseling also may be required to determine whether a given mutation is amenable to gene therapy.
Baseline evaluations are done when its a muscular skeletal disease timed function tests as well as lab tests and a study schedule is established, he said. In many of our studies, we see the patients very frequently, almost every day for the first two weeks. They stay in the area for up to a month. Because were often dealing with rare populations, that makes it convenient for us to evaluate these patients.
Byrne noted that gene therapy is not necessarily durable for the lifespan of the patient. Because the delivered gene does not integrate into the cells own DNA, it is not passed down to newly formed cells.
Some cells, particularly in the liver and muscle, continue to grow throughout childhood and AAV doesnt integrate, so its progressively less effective unless the cells being targeted, as in SMA, are not dividing, he said. Thats an example where newborn screening is critically important to better outcomes.
Mendell said he generally starts patients on prednisone one day before receiving gene therapy in order to suppress liver inflammation, and keeps them on it for 60 days after.
When were in the room, the first thing that happens is the gene is delivered. You push a button and get started, he said. Obviously it must be the correct gene. Its in there, but you cant see it.
The actual gene is delivered by intravenous (IV) infusion with a pump over a 90-minute period, Mendell said; anything faster than that could potentially cause harmful side effects.
We put IVs in both arms for continuous delivery in case one side gets clogged up. We dont want anything to stop gene delivery, he said. Meanwhile, the patient is constantly monitored for vital signs. We invite the whole family to stay together, and thats reassuring. Theres anxiety about gene therapy, but the potential benefits generally outweigh any risks involved.
Some patients may develop nausea and vomiting in the first one-to-three weeks following treatment. For this reason, blood is taken every two weeks for three months to check for side effects.
Mendell said he knows patients are responding to gene therapy by doing testing. In the case of Duchenne, he uses the North Star Ambulatory Assessment, which includes 17 timed tests such as climbing stairs, rising from a sitting position, and walking or running 100 meters. In addition, neck control is a very good indicator of efficacy among Duchenne boys, he said.
The FDA anticipates that within the next 10 years, it will approve up to 40 gene therapies for rare conditions. Mendell said the benefits of gene therapy for one condition in particular, SMA, are undeniable.
This is an absolutely devastating disease. In type 1 SMA, patients usually dont survive past age 2, and about 50% are gone by age 1, he said. Initially there was concern about giving this to infants, but we told the FDA we needed to test infants in order to save lives.
Continuing results from Mendells pivotal Phase 1 trial (NCT02122952) in 15 type 1 infants and along-term extension study (NCT03421977) have changed the way people view gene therapys potential in general.
After four years, he said, every patient in our trial went from being unable to sit to being able to, and several are able to walk. One patient was treated 28 days after birth, and now four years later, hes off to school. What Barry and I do is very gratifying, and we thank our patients and their families for this opportunity.
Total Posts: 85
Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.
More here:
Experts Barry Byrne, Jerry Mendell Lead NORD Webinar on Gene Therapy - SMA News Today
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit [Last Updated On: April 26th, 2012] [Originally Added On: April 26th, 2012]
- Protein could be key for drugs that promote bone growth [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- Study sheds light on genetic 'clock' in embryonic cells [Last Updated On: November 14th, 2012] [Originally Added On: November 14th, 2012]
- Study involving twin sisters provides clues for battling aggressive cancers [Last Updated On: February 9th, 2014] [Originally Added On: February 9th, 2014]
- Clues for battling aggressive cancers from twin sisters study [Last Updated On: February 11th, 2014] [Originally Added On: February 11th, 2014]
- Genetic cause found for premature ovarian failure [Last Updated On: March 6th, 2014] [Originally Added On: March 6th, 2014]
- Rutgers' Human Genetics Institute Wins $19 Million Federal Contract [Last Updated On: May 15th, 2014] [Originally Added On: May 15th, 2014]
- Elsevier Publishes Four New Books in Microbiology Portfolio [Last Updated On: November 13th, 2014] [Originally Added On: November 13th, 2014]
- Disease, Evolution, Neurology, and Drugs: Fruit Fly Research Continues to Teach Us About Human Biology [Last Updated On: February 28th, 2015] [Originally Added On: February 28th, 2015]
- "Big Brain" Gene Allowed for Evolutionary Expansion of Human Neocortex [Last Updated On: March 8th, 2015] [Originally Added On: March 8th, 2015]
- Director Molecular Genetics jobs in Rtp at LabCorp [Last Updated On: June 1st, 2015] [Originally Added On: June 1st, 2015]
- Molecular Genetics definition of Molecular Genetics in the ... [Last Updated On: June 4th, 2015] [Originally Added On: June 4th, 2015]
- molecular and human genetics | Momentum - The Baylor ... [Last Updated On: June 19th, 2015] [Originally Added On: June 19th, 2015]
- Molecular evolution - Wikipedia, the free encyclopedia [Last Updated On: July 16th, 2015] [Originally Added On: July 16th, 2015]
- The Rockefeller University Laboratory of Molecular Genetics [Last Updated On: July 21st, 2015] [Originally Added On: July 21st, 2015]
- Microbiology & Molecular Genetics - Rutgers New Jersey ... [Last Updated On: September 5th, 2015] [Originally Added On: September 5th, 2015]
- Clinical Genetics Congress | Clinical Genetics 2016 ... [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Molecular genetics - Wikipedia, the free encyclopedia [Last Updated On: September 28th, 2016] [Originally Added On: September 28th, 2016]
- Molecular Genetics - DNA, RNA, & Protein [Last Updated On: October 20th, 2016] [Originally Added On: October 20th, 2016]
- MCW: Microbiology and Molecular Genetics Department [Last Updated On: October 21st, 2016] [Originally Added On: October 21st, 2016]
- Newcastle Hospitals - Molecular Genetics [Last Updated On: October 21st, 2016] [Originally Added On: October 21st, 2016]
- Molecular evolution - Wikipedia [Last Updated On: October 23rd, 2016] [Originally Added On: October 23rd, 2016]
- Molecular Genetics (Stanford Encyclopedia of Philosophy) [Last Updated On: October 30th, 2016] [Originally Added On: October 30th, 2016]
- Molecular Genetics - mmrl.edu [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Molecular biology - Wikipedia [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Human Molecular Genetics - amazon.com [Last Updated On: November 12th, 2016] [Originally Added On: November 12th, 2016]
- Molecular Genetics Service - Great Ormond Street Hospital ... [Last Updated On: November 16th, 2016] [Originally Added On: November 16th, 2016]
- The Passions of Nazneen Rahman - San Francisco Classical Voice [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Genetic Testing for the Healthy - Harvard Medical School (registration) [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Fundraising page set up in memory of Nottingham's Maid Marian - Nottingham Post [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Dogs have their day at conference - Otago Daily Times [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- GGC Graduates Two from Medical Genetics Training Program - Index-Journal [Last Updated On: July 2nd, 2017] [Originally Added On: July 2nd, 2017]
- Irvine-based CombiMatrix in $33 million merger deal with Bay Area genetics firm - OCRegister [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- First of 10 expected BJC Investigators named - Washington University School of Medicine in St. Louis [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- Madhuri Hegde, PhD is Elected to the Board of the ACMG Foundation for Genetic and Genomic Medicine - Markets Insider [Last Updated On: August 7th, 2017] [Originally Added On: August 7th, 2017]
- Getting the word out: Seminar, walk put spotlight on Sickle Cell disease - Dothan Eagle [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Out of a fish gut study, researchers open new doors in intestinal health - Durham Herald Sun [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Gene-Silencing Finding May Lead to Better Understanding of Some ... - Genetic Engineering & Biotechnology News [Last Updated On: August 31st, 2017] [Originally Added On: August 31st, 2017]
- Molecular Genetics and Genomics Program - Wake Forest ... [Last Updated On: October 1st, 2017] [Originally Added On: October 1st, 2017]
- Genetics and Molecular Biology | Peer Reviewed Journal [Last Updated On: June 30th, 2018] [Originally Added On: June 30th, 2018]
- Leeds Genetics Laboratory - Leeds Teaching Hospitals NHS Trust [Last Updated On: July 17th, 2018] [Originally Added On: July 17th, 2018]
- Genetics and Molecular Biology Research - iMedPub [Last Updated On: August 2nd, 2018] [Originally Added On: August 2nd, 2018]
- Molecular Genetics | ARUP Laboratories [Last Updated On: August 7th, 2018] [Originally Added On: August 7th, 2018]
- Molecular Genetics - The Ohio State University [Last Updated On: August 21st, 2018] [Originally Added On: August 21st, 2018]
- Peer Reviewed Genetics and Molecular Biology Journals ... [Last Updated On: September 5th, 2018] [Originally Added On: September 5th, 2018]
- Department of Microbiology and Molecular Genetics [Last Updated On: October 7th, 2018] [Originally Added On: October 7th, 2018]
- Molecular Genetics Jobs, Employment | Indeed.com [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Genomic Career: Molecular Geneticist ($35,620-$101,030) [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Molecular Genetics, Biochemistry & Microbiology [Last Updated On: October 10th, 2018] [Originally Added On: October 10th, 2018]
- Molecular Genetics | Department of Pediatrics [Last Updated On: December 1st, 2018] [Originally Added On: December 1st, 2018]
- Graduate Molecular Genetics - University of Toronto [Last Updated On: January 25th, 2019] [Originally Added On: January 25th, 2019]
- Molecular Genetics - OCME - nyc.gov [Last Updated On: February 19th, 2019] [Originally Added On: February 19th, 2019]
- Molecular Genetics - University of Toronto [Last Updated On: March 6th, 2019] [Originally Added On: March 6th, 2019]
- Department of Microbiology, Immunology and Molecular Genetics [Last Updated On: March 13th, 2019] [Originally Added On: March 13th, 2019]
- Molecular Genetics and Cell Biology [Last Updated On: May 4th, 2019] [Originally Added On: May 4th, 2019]
- Molecular Reproduction, Development and Genetics at IISc [Last Updated On: May 18th, 2019] [Originally Added On: May 18th, 2019]
- Molecular genetics | biology | Britannica.com [Last Updated On: September 7th, 2019] [Originally Added On: September 7th, 2019]
- BCH N of 1 Trial Yields Approved Therapy for Single Rare Disease Patient - Clinical OMICs News [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- 5 habits of highly successful entrepreneurs revealed - GrowthBusiness.co.uk [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Leading by example: how AquaBounty, Oxford Biomedica, and Berkeley Lights have successfully brought products to market - SynBioBeta [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Blue Devil of the Week: Searching for Answers in the Genetic Code - Duke Today [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- New Viruses Found in Farmed and Wild Salmon - Hakai Magazine [Last Updated On: October 13th, 2019] [Originally Added On: October 13th, 2019]
- Veterinary Molecular Diagnostics Market to Reach at a CAGR of 8.48% by 2026 With NEOGEN CORPORATION , Thermo Fisher Scientific, Inc., Virbac, General... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Quantabio to Showcase Industry's Fastest qPCR-based NGS Library Quantification Kit and HiFi PCR Mix at American Society of Human Genetics Annual... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Top Researchers to Present Discoveries Made Possible by Bionanos Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting - Yahoo... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Bionano Genomics Announces Adoption of Its Saphyr System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for... [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Racial Disparities In NIH R01 Funding May Be Partly Caused By Topic Choice : Shots - Health News - NPR [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Denison presents: 'Christianity, Race, and the Haunting of the Biomedical Sciences' - The Newark Advocate [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- This image shows the aftermath of two galaxies colliding - CTV News [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Meet The Cast of Charmed Season 2 - TVOvermind [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Inherited Learning? It Happens, but How Is Uncertain - Quanta Magazine [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Where do Canada's federal parties stand on research funding? - Varsity [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- The double bind faced by black research applicants - University World News [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Excessive Brain Activity Linked to Shorter Life Span - PsychCentral.com [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board - PRNewswire [Last Updated On: October 21st, 2019] [Originally Added On: October 21st, 2019]
- Lupus Study Illustrates the Importance of Diversity in Genetic Research - Nature World News [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Interpace to Present Data at the ATA Annual Meeting - GlobeNewswire [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Pacific subspecies of fin whales has been revealed by new genetic study - Oceanographic - Oceanographic Magazine [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- Genetic Study: Shared Molecular Pathway Might Influence Susceptibility to Lack of Oxygen Caused by Sleep-disordered Breathing and Other Lung Illnesses... [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]
- ERT to Treat Pompe May Work Better in Combo with Blood Pressure Medication, Study Says - Pompe Disease News [Last Updated On: October 30th, 2019] [Originally Added On: October 30th, 2019]